Neutrophil-fibroblast Crosstalk Drives Immunofibrosis in Crohn's Disease Through IFNα Pathway

Introduction: Crohn's disease (CD) is characterized by chronic inflammation and intestinal fibrosis leading to lifelong complications. However, the disease pathogenesis remains elusive, and the therapeutic options are limited. Here, we investigated the interaction between neutrophils and intestinal fibroblasts in the development of CD immunofibrosis, a disease mechanism predisposing to inflammatory and fibrotic complications.

Methods: Peripheral neutrophils, enriched neutrophil extracellular traps (eNETs), serum, primary intestinal fibroblasts (PIFs) and intestinal biopsies from CD, ulcerative colitis (UC) patients, and healthy individuals (HI), were studied. Transcriptome analysis of neutrophils, multi-cytokine profiling and cell-based functional assays at mRNA/protein level were performed.

Results: Compared to UC, PIFs from CD patients, independently to the presence of strictures, displayed a distinct pro-fibrotic phenotype characterized by negative Krüppellike Factor-2 (KLF2) and increased cellular communication network factor-2 (CCN2) expression leading to collagen production. In both UC and CD, PIFs-derived IL-8 acted as a culprit chemoattractant for neutrophils in the intestine, where CD neutrophils were accumulated close to fibrotic lesions. Functionally, only CD neutrophils via eNETs induced a CD-like phenotype in HI PIFs, suggesting their fibrotic plasticity. High IFNa in serum and IFΝ-responsive signature in peripheral neutrophils were observed in CD, distinguishing it from UC. Moreover, CD serum stimulated the release of fibrogenic eNETs from neutrophils in an IFNa-dependent manner, suggesting the priming role of IFNa in circulating neutrophils. Inhibition of eNETs or JAK signaling in neutrophils or PIFs prevented the neutrophil-mediated fibrotic effect on PIFs. Furthermore, both serum IFNa levels and mRNA levels of key IFN signaling components in neutrophils were wellcorrelated with CD severity.

Conclusions: This study reveals the important role of the IFNa/neutrophil/fibroblast axis in CD immunofibrosis, suggesting candidate biomarkers and putative therapeutic targets.

Citing Articles

Anemia in diabetes mellitus: Pathogenetic aspects and the value of early erythropoietin therapy.

Antoniadou C, Gavriilidis E, Ritis K, Tsilingiris D Metabol Open. 2025; 25:100344.

PMID: 39886103 PMC: 11780985. DOI: 10.1016/j.metop.2024.100344.

The Cell-Specific Effects of JAK1 Inhibitors in Ulcerative Colitis.

Veltkamp S, Voorneveld P J Clin Med. 2025; 14(2).

PMID: 39860613 PMC: 11766026. DOI: 10.3390/jcm14020608.

References

Satsangi J, Silverberg M, Vermeire S, Colombel J . The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55(6):749-53. PMC: 1856208. DOI: 10.1136/gut.2005.082909. View

Garcia-Romo G, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z . Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011; 3(73):73ra20. PMC: 3143837. DOI: 10.1126/scitranslmed.3001201. View

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

Mitsios A, Arampatzioglou A, Arelaki S, Mitroulis I, Ritis K . NETopathies? Unraveling the Dark Side of Old Diseases through Neutrophils. Front Immunol. 2017; 7:678. PMC: 5225098. DOI: 10.3389/fimmu.2016.00678. View

Haberman Y, Karns R, Dexheimer P, Schirmer M, Somekh J, Jurickova I . Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun. 2019; 10(1):38. PMC: 6318335. DOI: 10.1038/s41467-018-07841-3. View

Mo A, Marigorta U, Arafat D, Chan L, Ponder L, Jang S . Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease. Genome Med. 2018; 10(1):48. PMC: 6020373. DOI: 10.1186/s13073-018-0558-x. View

Strober W, Watanabe T . NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease. Mucosal Immunol. 2011; 4(5):484-95. PMC: 3773501. DOI: 10.1038/mi.2011.29. View

Angelidou I, Chrysanthopoulou A, Mitsios A, Arelaki S, Arampatzioglou A, Kambas K . REDD1/Autophagy Pathway Is Associated with Neutrophil-Driven IL-1β Inflammatory Response in Active Ulcerative Colitis. J Immunol. 2018; 200(12):3950-3961. DOI: 10.4049/jimmunol.1701643. View

Mitroulis I, Chrysanthopoulou A, Divolis G, Ioannidis C, Ntinopoulou M, Tasis A . A gene expression map of host immune response in human brucellosis. Front Immunol. 2022; 13:951232. PMC: 9376622. DOI: 10.3389/fimmu.2022.951232. View

10.

Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross W, Werb Z . Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009; 15(6):623-5. PMC: 2760083. DOI: 10.1038/nm.1959. View

11.

Schroeder K, Tremaine W, Ilstrup D . Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987; 317(26):1625-9. DOI: 10.1056/NEJM198712243172603. View

12.

Pfister H . Neutrophil Extracellular Traps and Neutrophil-Derived Extracellular Vesicles: Common Players in Neutrophil Effector Functions. Diagnostics (Basel). 2022; 12(7). PMC: 9323717. DOI: 10.3390/diagnostics12071715. View

13.

Ostrowski J, Goryca K, Lazowska I, Rogowska A, Paziewska A, Dabrowska M . Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases. Sci Rep. 2019; 9(1):7190. PMC: 6510750. DOI: 10.1038/s41598-019-43699-1. View

14.

Masuta Y, Minaga K, Kurimoto M, Sekai I, Hara A, Omaru N . Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates Toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme A expression. Int Immunol. 2022; 35(2):79-94. DOI: 10.1093/intimm/dxac045. View

15.

Banks C, Bateman A, Payne R, Johnson P, Sheron N . Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol. 2002; 199(1):28-35. DOI: 10.1002/path.1245. View

16.

Garrido-Trigo A, Corraliza A, Veny M, Dotti I, Melon-Ardanaz E, Rill A . Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease. Nat Commun. 2023; 14(1):4506. PMC: 10372067. DOI: 10.1038/s41467-023-40156-6. View

17.

Best W, Becktel J, SINGLETON J, KERN Jr F . Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70(3):439-44. View

18.

Loftus Jr E . Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126(6):1504-17. DOI: 10.1053/j.gastro.2004.01.063. View

19.

Dehghan M, Wong G, Neuberger E, Kin C, Rieder F, Park K . Worse outcomes and higher costs of care in fibrostenotic Crohn's disease: a real-world propensity-matched analysis in the USA. BMJ Open Gastroenterol. 2021; 8(1). PMC: 8689124. DOI: 10.1136/bmjgast-2021-000781. View

20.

Chrysanthopoulou A, Gkaliagkousi E, Lazaridis A, Arelaki S, Pateinakis P, Ntinopoulou M . Angiotensin II triggers release of neutrophil extracellular traps, linking thromboinflammation with essential hypertension. JCI Insight. 2021; 6(18). PMC: 8492353. DOI: 10.1172/jci.insight.148668. View